Company logo

SLP - Simulations Plus, Inc.

NASDAQ -> Healthcare -> Health Information Services
Lancaster, United States
Type: Equity

SLP price evolution
SLP
(in millions $) 1 Oct 2024 30 Jul 2024 31 Mar 2024 31 Jan 2024
Current assets
Cash $109.09 $37.03 $39.79
Short term investments $9.88 $71.47 $74.1
Net receivables $15.04 $10.14 $13.11 $10.35
Inventory
Total current assets $39.34 $135.62 $127.96 $129.69
Long term investments $9.02
Property, plant & equipment $1.84 $1.83 $1.91 $1.6
Goodwill & intangible assets $51.92 $52.24 $52.23
Total noncurrent assets $57.08 $66.02 $56.09
Total investments $9.88 $80.5 $74.1
Total assets $196.64 $192.69 $193.97 $185.78
Current liabilities
Accounts payable $0.6 $4.47 $5.47 $2.61
Deferred revenue $1.44 $2.46 $2.66
Short long term debt $0.41 $0.42 $0.42
Total current liabilities $12.07 $11.32 $14.53 $8.59
Long term debt $0.51 $0.61 $0.67
Total noncurrent liabilities $0.51 $2.41 $4.85
Total debt $0.92 $1.03 $1.09
Total liabilities $14.21 $11.83 $16.93 $13.44
Shareholders' equity
Retained earnings $30.35 $30.71 $28.78 $25.95
Other shareholder equity -$0.25 -$0.3 -$0.21 -$0.2
Total shareholder equity $180.86 $177.04 $172.34
(in millions $) 1 Oct 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Current assets
Cash $57.52 $51.57 $36.98
Short term investments $57.94 $76.67 $86.62
Net receivables $15.04 $10.2 $13.79 $13
Inventory
Total current assets $39.34 $130.37 $146.79 $139.31
Long term investments
Property, plant & equipment $1.84 $1.92 $2.05 $3.11
Goodwill & intangible assets $51.95 $39.1 $37.5
Total noncurrent assets $55.73 $41.59 $40.66
Total investments $57.94 $76.67 $86.62
Total assets $196.64 $186.1 $188.38 $179.98
Current liabilities
Accounts payable $0.6 $3.39 $0.23 $0.39
Deferred revenue $3.1 $2.86 $0.65
Short long term debt $0.44 $0.46 $0.38
Total current liabilities $12.07 $11.99 $7.74 $11.57
Long term debt $0.76 $0.94 $0.9
Total noncurrent liabilities $4.08 $2.4 $2.62
Total debt $1.2 $1.4 $1.28
Total liabilities $14.21 $16.07 $10.13 $14.2
Shareholders' equity
Retained earnings $30.35 $25.2 $40.04 $32.41
Other shareholder equity -$0.25 -$0.14 -$0.31 -$0.04
Total shareholder equity $170.03 $178.25 $165.78
(in millions $) 31 Jan 2025 1 Oct 2024 30 Jul 2024 31 Mar 2024
Revenue
Total revenue $18.66 $18.3
Cost of revenue $5.08
Gross Profit $6.83 $13.22
Operating activities
Research & development $1.31
Selling, general & administrative $7.47
Total operating expenses $7.98 $8.78
Operating income $4.44
Income from continuing operations
EBIT $5.25
Income tax expense $0.02 $1.22
Interest expense $0.64
Net income
Net income $0.84 $4.03
Income (for common shares) $4.03
(in millions $) 1 Oct 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Revenue
Total revenue $70.01 $59.58 $53.91 $46.47
Cost of revenue $11.63 $10.82 $10.6
Gross Profit $43.15 $47.95 $43.08 $35.87
Operating activities
Research & development $4.5 $3.21 $4.05
Selling, general & administrative $34.72 $24.96 $20.57
Total operating expenses $37.02 $39.22 $28.17 $24.61
Operating income $8.72 $14.91 $11.25
Income from continuing operations
EBIT $11.7 $15.12 $11.11
Income tax expense $2.46 $1.73 $2.63 $1.3
Interest expense $4.64 $0.02
Net income
Net income $9.95 $9.96 $12.48 $9.78
Income (for common shares) $9.96 $12.48 $9.78
(in millions $) 1 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $3.14 $4.03 $1.95
Operating activities
Depreciation $1.26 $1.1 $1.09
Business acquisitions & disposals
Stock-based compensation $1.79 $1.78 $1.36
Total cash flows from operations $5.68 $5.81 $0.16
Investing activities
Capital expenditures -$0.92 -$1.3 -$0.85
Investments $70.87 -$6 -$15.77
Total cash flows from investing -$53.97 $69.91 -$7.52 -$16.86
Financing activities
Dividends paid -$4.8 -$1.2 -$1.2 -$1.2
Sale and purchase of stock $0.16 $0.15 $0.16
Net borrowings -$2.5
Total cash flows from financing -$6.57 -$3.54 -$1.05 -$1.03
Effect of exchange rate
Change in cash and equivalents -$47.21 $72.06 -$2.76 -$17.73
(in millions $) 1 Oct 2024 31 Dec 2023 31 Dec 2022 31 Dec 2021
Net income $9.96 $12.48 $9.78
Operating activities
Depreciation $3.84 $3.57 $3.59
Business acquisitions & disposals -$8.22
Stock-based compensation $4.83 $3.04 $2.75
Total cash flows from operations $21.86 $17.9 $19.2
Investing activities
Capital expenditures -$3.67 -$3.97 -$4.58
Investments $19.86 $8.28 -$22.17
Total cash flows from investing -$53.97 $7.37 $4.3 -$26.74
Financing activities
Dividends paid -$4.8 -$4.81 -$4.85 -$4.81
Sale and purchase of stock -$18.46 $0.89 $1.46
Net borrowings -$3.67 -$1.33
Total cash flows from financing -$6.57 -$23.27 -$7.62 -$4.68
Effect of exchange rate
Change in cash and equivalents -$47.21 $5.96 $14.58 -$12.22
Fundamentals
Market cap $573.06M
Enterprise value N/A
Shares outstanding 20.05M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 3.26
Quick ratio N/A